A Study of Detection of Paroxysmal Events Utilizing Computer Vision and Machine Learning - Nelli

NCT ID: NCT05606575

Last Updated: 2026-02-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-01

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nelli is a video-based non-EEG physiological seizure monitoring system. This study is a blinded comparison of Nelli's identified events to gold-standard video EEG review in at-rest pediatric subjects with suspected motor seizures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Automated analysis of video recordings to detect seizures, assisted by modern methods of machine learning, holds great promise to address this issue. Increased computational power has made it possible to implement complex image recognition tasks and machine learning in everyday use. NelliĀ® software is designed to use computer vision and machine learning-based algorithms to automatically detect seizure events. This study will provide evidence that Nelli software can identify seizure events and deliver objective data to clinicians for evaluation of seizure management.

This study is being conducted to validate the Nelli Software's ability to identify periods of audio

/video data that contain recordings of patients experiencing seizures (or seizure-like events) during periods of rest. The software's performance will be compared to the gold standard, expert review of video EEG data.

Nelli Software will review the audio and video data and independently identify events with positive motor manifestations. The outcomes of event identification will be compared between epileptologists and the Nelli Software. For each category of event captured the positive percent agreement will be calculated using the exact binomial method. The primary endpoint of this study is to demonstrate that Nelli is able to identify seizures that have a positive motor component with a sensitivity of \>70% (lower 95% CI) and with a false discovery rate (FDR) comparable to similar devices on the market.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epilepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nelli

Nelli is a non-EEG physiological signal-based seizure detection and quantification device that is indicated for use as an adjunct to seizure monitoring during periods of rest. The device utilizes automated analysis of audio and video (media) data collected via the personal recording unit (PRU) hardware accessory to identify epileptic and non-epileptic seizure events with a positive motor component.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject shall sign informed consent.
* Subject is between 6 and 21 years.
* Subjects shall be undergoing video-EEG monitoring for routine clinical purposes.
* Subjects shall have a suspected history of motor seizures.
* Subject shall be able to understand and sign written informed consent or have a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments.

Exclusion Criteria

* None identified.
Minimum Eligible Age

6 Years

Maximum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Neuro Event Labs Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James Wheless, MD

Role: PRINCIPAL_INVESTIGATOR

The University of Tennessee Health Science Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Tennessee Health Science Center

Memphis, Tennessee, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21-08296-XP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Feasibility of Stimulating the Visual Cortex in Blind
NCT02747589 ACTIVE_NOT_RECRUITING NA
Effectiveness of VestAid App
NCT06683417 NOT_YET_RECRUITING NA
Spectacles Lens in Concussed Kids
NCT03123822 TERMINATED NA
Vestibular Infant Screening - Rehabilitation
NCT06177132 NOT_YET_RECRUITING NA